发明名称 Thiadiazoles as CXC- and CC- chemokine receptor ligands
摘要 Disclosed are novel compounds of the formula: and the pharmaceutically acceptable salts and solvates thereof. Examples of groups comprising Substituent A include heteroaryl, aryl, heterocycloalkyl, cycloalkyl, aryl, alkynyl, alkenyl, aminoalkyl, alkyl or amino. Examples of groups comprising Substituent B include aryl and heteroaryl. Also disclosed is a method of treating a chemokine mediated diseases, such as, cancer, angiogenisis, angiogenic ocular diseases, pulmonary diseases, multiple sclerosis, rheumatoid arthritis, osteoarthritis, stroke and ischemia reperfusion injury, pain (e.g., acute pain, acute and chronic inflammatory pain, and neuropathic pain) using a compound of formula IA.
申请公布号 US7786149(B2) 申请公布日期 2010.08.31
申请号 US20070861870 申请日期 2007.09.26
申请人 SCHERING CORP.;PHARMACOPEIA DRUG DISCOVERY, INC. 发明人 BIJU PURAKKATTLE J.;TAVERAS ARTHUR G.;MERRITT J. ROBERT;BALDWIN JOHN J.;YU YOUNONG;ZHENG JUNYING;CHAO JIANHUA;AKI CYNTHIA J.
分类号 C07D285/06;A01N43/82;C07D285/10;C07D417/12;C07D417/14 主分类号 C07D285/06
代理机构 代理人
主权项
地址